Publications found:
73,128
Sort by:
Bronchitis - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Bronchitis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Bronchitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
129 pages
Choroidal Neovascularization - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Choroidal Neovascularization (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Choroidal Neovascularization and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
57 pages
Interstitial Cystitis (Painful Bladder Syndrome) - Pipeline Review, H2 2019
US$ 2,000.00
... Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Interstitial Cystitis (Painful Bladder Syndrome) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
88 pages
Bone Fracture - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Bone Fracture (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Bone Fracture and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
75 pages
Ependymoma - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Ependymoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Ependymoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
237 pages
Systemic Idiopathic Juvenile Arthritis - Pipeline Review, H2 2019
US$ 2,000.00
... . The Systemic Idiopathic Juvenile Arthritis (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Systemic Idiopathic Juvenile Arthritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
58 pages
Muscle Atrophy - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Muscle Atrophy (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Muscle Atrophy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
37 pages
Xerostomia - Pipeline Review, H2 2019
US$ 2,000.00
... and Dental Disorders) pipeline guide also reviews of key players involved in therapeutic development for Xerostomia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
37 pages
Human Growth Hormone (hGH) Market by Application (Growth Hormone Deficiency, Prader-Willi Syndrome, Turner Syndrome, Small for Gestational Age, and Others), Route of Administration (Intravenous, Intramuscular, Subcutaneous, and Oral), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, and Online Pharmacy): Global Opportunity Analysis and Industry Forecast, 2019–2026
US$ 5,370.00
The global human growth hormone market was valued at $2,840.70 million in 2018 and is expected to reach $5,563.60 million by 2026, registering a CAGR of 8.6% from 2019 to 2026. Human growth hormone is...
November 2019
212 pages
Fibromyalgia - Pipeline Review, H2 2019
US$ 2,000.00
... . The Fibromyalgia (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Fibromyalgia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
111 pages
Lateral Flow Immunoassay (LFIA) Based Rapid Test Market by Application Type (Infectious Disease, Pregnancy & Fertility, Toxicology and Others), Technique type (Competitive Assay, Sandwich Assay, and Multiplex Detection Assay), and End User (Hospitals & Clinics, Diagnostic Laboratories, Home Care and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026
US$ 5,370.00
The global LFIA based rapid test market was valued at $4,725 million in 2018, and is projected to reach $8,494 million by 2026, registering a CAGR of 7.6% from 2019 to 2026. Lateral flow tests, or lat...
November 2019
393 pages
Healthcare Market Consolidation: Who will not survive?
US$ 6,500.00
... critical to the development and implementation of effective marketing and R&D programs. In the dynamic and fragmented Healthcare industry, besieged by intense competition and rapid ...
November 2019
-
Global Precision Medicine Market (2018-2023)
US$ 2,950.00
... 2018–2023. Big data analytics is also expected to show fast growth during the forecast period. Regional insights North America leads the global precision medicine market ...
November 2019
90 pages
